← Back

RC365 Holding PLC

RC365 Holding plc, an investment holding company, operates as a fintech solutions service provider in Hong Kong, the United Kingdom, and Japan. It offers IT support and security, online and offline payment gateway solutions, credit card issuance, top up, and computer graphic design and animation services. The company also provides asset linked credit card solutions; foreign exchange services; media production services; money lending services; business virtual account supporting services; and enterprise resource planning (ERP) services. In addition, it offers exchange, remittance, and licensed small payment services; cybersecurity and IT managed support; prepaid card advisory; regulated money; and IT software development and payment services. The company serves multinational merchants, SMEs, and individual retail customers. RC365 Holding plc was founded in 2013 and is based in London, the United Kingdom.

Price · split & dividend adjusted
News & notes moving RCGH.LSE
RCGH.LSE

Arrow Exploration brings Icaco-2 well on production at 830 barrels per day

Arrow Exploration Corp has brought its Icaco-2 well in Colombia on production at around 830 barrels per day gross, taking total corporate output to approximately 5,000 barrels of oil equivalent per day. CEO Marshall Abbott says the Icaco discovery may be material to Arrow, with horizontal and vertical development wells already planned. Frontier IP Group PLC has raised £4 million through a placing and subscription at 12p per share, with six directors participating in the subscription element, and a retail offer through BookBuild aims to raise a further £400,000 before closing at 5pm on 18 June. RC365 Holding PLC has signed a point-of-sale agreement with StarCruises International to deploy its RC3.0 payments platform across cruise operations in Asia, including cryptocurrency acceptance and multi-language support. Coiled Therapeutics has appointed two senior oncologists to a newly formed medical advisory board guiding its lead cancer drug AO-252 through phase I trials, with Professor Guru Sonpavde and Dr Alexander Spira shaping clinical strategy as the programme moves toward expansion cohorts in the second half of 2026. Genflow Biosciences Ltd has been invited to present results from its SLAB dog longevity study at the Animal Longevity Summit in Toronto in October, with the study evaluating its SIRT6 gene therapy in aged beagles concluding this month. Pan African Resources PLC will join the FTSE 250 from 23 June, following the court sanction of its all-share acquisition of Emmerson Resources, and also joins the FTSE 350, FTSE All-Share and related indices.
Yahoo Finance·70dRead more ▾